Filing Flows › Gilead Sciences (GILD) › Operating margin
Gilead Sciences (GILD) operating margin by quarter
Gilead Sciences' operating margin was 41.7% in Q3 2026 (third quarter 2026), +4.6 pts from Q1 2026. Over the last 6 quarters it ranged from 25.0% (Q4 2025) to 42.8% (Q3 2025).
| Quarter | Operating margin | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | 41.7% | +4.6 pts | -1.1 pts |
| Q1 2026 | 37.2% | +12.1 pts | +3.6 pts |
| Q4 2025 | 25.0% | -17.8 pts | — |
| Q3 2025 | 42.8% | +7.9 pts | — |
| Q2 2025 | 34.9% | +1.4 pts | — |
| Q1 2025 | 33.6% | — | — |
Q3 2026 at a glance
Gilead Sciences, Q3 2026: revenue $8.3B (+7% year over year), operating margin 41.7%, net earnings $2.4B, operating cash flow $5.0B. The chart follows the revenue to costs, profit and cash.
Questions
What is Gilead Sciences' operating margin?
Gilead Sciences' operating margin was 41.7% in Q3 2026 (third quarter 2026), +4.6 pts from Q1 2026.
How has Gilead Sciences' operating margin changed?
Over the last 6 quarters it ranged from 25.0% (Q4 2025) to 42.8% (Q3 2025).